These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 29948255

  • 1. Predictors of intravenous immunoglobulin-resistant Kawasaki disease in children: a meta-analysis of 4442 cases.
    Li X, Chen Y, Tang Y, Ding Y, Xu Q, Sun L, Qian W, Qian G, Qin L, Lv H.
    Eur J Pediatr; 2018 Aug; 177(8):1279-1292. PubMed ID: 29948255
    [Abstract] [Full Text] [Related]

  • 2. Predictors for intravenous immunoglobulin resistance and coronary artery lesions in Kawasaki disease.
    Xie T, Wang Y, Fu S, Wang W, Xie C, Zhang Y, Gong F.
    Pediatr Rheumatol Online J; 2017 Mar 21; 15(1):17. PubMed ID: 28320400
    [Abstract] [Full Text] [Related]

  • 3. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 21; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM, Özdemir R, Meşe T, Küçük M, Öner T, Devrim İ, Bayram N, Güven B, Tavlı V.
    Turk J Pediatr; 2019 May 21; 61(5):648-656. PubMed ID: 32104995
    [Abstract] [Full Text] [Related]

  • 5. The prognostic role of abnormal liver function in IVIG unresponsiveness in Kawasaki disease: a meta-analysis.
    Liu L, Yin W, Wang R, Sun D, He X, Ding Y.
    Inflamm Res; 2016 Feb 21; 65(2):161-8. PubMed ID: 26645912
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of laboratory predictors for intravenous immunoglobulin resistance and coronary artery aneurysm in Kawasaki Disease before and after therapy.
    Liu J, Ye B, Su D, Qin S, Zhao W, Pang Y.
    Clin Rheumatol; 2023 Jan 21; 42(1):167-177. PubMed ID: 36129563
    [Abstract] [Full Text] [Related]

  • 7. Prediction of intravenous immunoglobulin resistance in Kawasaki disease in children.
    Wu S, Liao Y, Sun Y, Zhang CY, Zhang QY, Yan H, Qi JG, Liu XQ, Chen YH, Wang YL, Li XY, Jin HF, Du JB.
    World J Pediatr; 2020 Dec 21; 16(6):607-613. PubMed ID: 32232677
    [Abstract] [Full Text] [Related]

  • 8. Meta-analysis of factors predicting resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Baek JY, Song MS.
    Korean J Pediatr; 2016 Feb 21; 59(2):80-90. PubMed ID: 26958067
    [Abstract] [Full Text] [Related]

  • 9. Relationship between ocular manifestations, laboratory findings, echocardiographic findings, and intravenous immunoglobulin resistance in Kawasaki disease.
    Jari M, Esmaeili H.
    Pediatr Rheumatol Online J; 2024 May 01; 22(1):50. PubMed ID: 38693550
    [Abstract] [Full Text] [Related]

  • 10. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
    J Pediatr; 2006 Aug 01; 149(2):237-40. PubMed ID: 16887442
    [Abstract] [Full Text] [Related]

  • 11. The expression of autophagy markers in IVIG-resistant Kawasaki disease and the establishment of prediction model.
    Zhou Y, Wu Y, Yuan C, Yin W, Wang B, Ding Y.
    BMC Pediatr; 2023 Dec 19; 23(1):642. PubMed ID: 38114939
    [Abstract] [Full Text] [Related]

  • 12. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 19; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 13. Higher efficacy of infliximab than immunoglobulin on Kawasaki disease, a meta-analysis.
    Li X, Tang Y, Ding Y, Chen Y, Hou M, Sun L, Qian G, Qin L, Lv H.
    Eur J Pharmacol; 2021 May 15; 899():173985. PubMed ID: 33652059
    [Abstract] [Full Text] [Related]

  • 14. Intravenous immunoglobulin treatment responsiveness depends on the degree of CD8+ T cell activation in Kawasaki disease.
    Ye Q, Gong FQ, Shang SQ, Hu J.
    Clin Immunol; 2016 Oct 15; 171():25-31. PubMed ID: 27519954
    [Abstract] [Full Text] [Related]

  • 15. Serum amyloid A as a biomarker for immunoglobulin resistance in Kawasaki disease.
    Huang XB, Zhao S, Liu ZY, Xu YY, Deng F.
    Ann Med; 2023 Oct 15; 55(2):2264315. PubMed ID: 37870383
    [Abstract] [Full Text] [Related]

  • 16. [Therapeutic effectiveness of intravenous immunoglobulin at 1 g/kg and 2 g/kg on Kawasaki disease: a comparative and follow-up study].
    Qin LJ, Wang HW, Hu XF, Liu QJ, Shi H, Wei YX, Chen QJ, Cheng PX.
    Zhonghua Er Ke Za Zhi; 2006 Dec 15; 44(12):891-5. PubMed ID: 17254453
    [Abstract] [Full Text] [Related]

  • 17. Risk Factors of Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease: A Meta-Analysis of Case-Control Studies.
    Liu G, Wang S, Du Z.
    Front Pediatr; 2020 Dec 15; 8():187. PubMed ID: 32373568
    [Abstract] [Full Text] [Related]

  • 18. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
    Am J Ther; 2016 Dec 15; 23(6):e1293-e1299. PubMed ID: 25611359
    [Abstract] [Full Text] [Related]

  • 19. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q.
    BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091
    [Abstract] [Full Text] [Related]

  • 20. [A retrospective analysis of 602 Kawasaki disease cases with electronic data capture system].
    Xie L, Zhou C, Wang R, Xiao T, Shen J, Huang M.
    Zhonghua Er Ke Za Zhi; 2015 Jan 17; 53(1):34-9. PubMed ID: 25748402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.